Vasundhara Rasayans P/B Ratio
Vasundhara Rasayans (VRL) P/B ratio is 0.98 (Low), book value per share ₹120.00 vs Healthcare average P/B of -0.94 — Low - Trading below book value, may indicate undervaluation. Compare with VRL stock valuation models to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
VRL P/B Ratio — Valuation Insights & Book Value Analysis
Vasundhara Rasayans price-to-book ratio interpretation, valuation status and historical context — current P/B 0.98 (Low). For live price, earnings yield and the full fundamental profile, see VRL stock price BSE.
- Stock appears undervalued with PB of 0.98, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 51.7% below historical average
- Trading at premium to sector average PB of -0.94
Vasundhara Rasayans P/B Ratio Historical Trend
VRL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Vasundhara Rasayans 52-week for the annual high/low range and current price position.
VRL Historical P/B Ratio — Book Value Per Share & Year-End Price
Vasundhara Rasayans annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.42 | ₹120.0 | ₹170.10 | ₹36 | Moderate |
| 2024 | 2.72 | ₹106.67 | ₹290.50 | ₹32 | Moderate |
| 2023 | 2.19 | ₹90.0 | ₹197.50 | ₹27 | Moderate |
| 2022 | 1.78 | ₹73.33 | ₹130.85 | ₹22 | Moderate |
| 2021 | 2.04 | ₹66.67 | ₹136.10 | ₹20 | Moderate |
VRL vs Healthcare Peers — P/B Ratio Comparison
Vasundhara Rasayans P/B 0.98 vs Healthcare average -0.94, median 0.6 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |